Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Updated daily

Drug recalls

Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.

Class IIITerminatedApr 1, 2015AIR COMPRESSEDFailed Impurities/Degradation Specification; out of specification results for carbon dioxideMatheson, Inc. · D-0423-2015Class IITerminatedApr 1, 2015Haloperidol Decanoate InjectionLack of Assurance of Sterility; due to leaking vialsMylan Institutional LLC · D-0422-2015Class IITerminatedApr 1, 2015Haloperidol Decanoate InjectionLack of Assurance of Sterility; due to leaking vialsMylan Institutional LLC · D-0421-2015Class IIITerminatedApr 1, 2015Fentanyl Citrate InjFailed Impurities/Degradation Specifications; 12 month stability testing.West-Ward Pharmaceutical Corporation · D-0420-2015Class IITerminatedMar 25, 2015Antacid Liquid Regular Strength Antacid & Anti-GasMicrobial Contamination of Non-Sterile Products: Lots failed microbiological testing at the 12-month time point.Tarmac Products, Inc. · D-0419-2015Class IITerminatedMar 25, 20155% DEXTROSE InjectionLack of Assurance of Sterility: there is a potential for solution to leak at the administrative port of the primary container.Hospira Inc. · D-0417-2015Class IITerminatedMar 25, 2015RIFAMPIN for InjectionLack of Assurance of Sterility: Firm is recalling two injectable products due to concerns with quality control processes.Heritage Pharmaceuticals, Inc. · D-0416-2015Class IITerminatedMar 25, 2015Colistimethate for Injection USPLack of Assurance of Sterility: Firm is recalling two injectable products due to concerns with quality control processes.Heritage Pharmaceuticals, Inc. · D-0415-2015Class IITerminatedMar 25, 2015Ergoloid MesylatesFailed Impurities/Degradation Specifications: during long-term stability testing.Mutual Pharmaceutical Company, Inc. · D-0414-2015Class IIITerminatedMar 25, 2015Nicardipine Hydrochloride InjectionSubpotent Drug and Failed Impurities/Degradation SpecificationsMylan Institutional LLC · D-0413-2015Class IIITerminatedMar 25, 2015DOXOrubicin Hydrochloride InjectionCorrect Labeled Product Mispack: Ifosfamide Injection 50 mg/mL, 60 mL, correctly labeled vial may have been mis-packaged in a carton labeled Doxorubicin Hydrochloride...Mylan Institutional LLC · D-0412-2015Class IITerminatedMar 18, 2015PROMETHAZINE DM SYRUPPresence of Foriegn Substance: Plastic cap closure particulates may be present in the product.Qualitest Pharmaceuticals · D-0411-2015Class IITerminatedMar 18, 2015DICOPANOLMicrobial Contamination of a Non-Sterile Product: Kit component is contaminated with Burkholderia multivorans.Fusion Pharmaceuticals, LLC · D-0410-2015Class IIITerminatedMar 18, 2015Simvastatin TabletsFailed Impurities/Degradation Specifications: Product failed a known impurity specification.Micro Labs Usa, Inc S · D-0409-2015Class IIITerminatedMar 18, 2015Simvastatin TabletsFailed Impurities/Degradation Specifications: Product failed a known impurity specification.Micro Labs Usa, Inc S · D-0408-2015Class IIITerminatedMar 18, 2015Simvastatin TabletsFailed Impurities/Degradation Specifications: Product failed a known impurity specification.Micro Labs Usa, Inc S · D-0407-2015Class IITerminatedMar 11, 2015Vancomycin Hydrochloride CapsulesSubpotent DrugActavis Inc · D-0406-2015Class IITerminatedMar 11, 2015Fluticasone Propionate Nasal SprayFailed Stability Specifications: Out of specification for preservative, benazalkonium chloride.Akorn, Inc. · D-0405-2015Class IIITerminatedMar 11, 2015Oxecta(TM)Failed Impurities/Degradation SpecificationsPfizer Inc. · D-0404-2015Class IIITerminatedMar 11, 2015Oxecta(TM)Failed Impurities/Degradation SpecificationsPfizer Inc. · D-0403-2015Class IIITerminatedMar 11, 2015Quinapril Tablets USPSubpotent DrugAVKARE Inc. · D-0402-2015Class IIITerminatedMar 11, 2015Quinapril Tablets USPSubpotent DrugAVKARE Inc. · D-0401-2015Class IIITerminatedMar 11, 2015Z-COTE HP 1 TRANSPARENT ZINC OXIDELabeling: Illegible label. Writing is rubbing off of labels.Nanophase Technologies Corporation · D-0400-2015Class IITerminatedMar 11, 2015Atracurium Besylate InjectionLack of Assurance of Sterility: Recall initiated due to FDA observations pertaining to aseptic and GMP practices at the manufacturers site potentially impacting product...Sagent Pharmaceuticals Inc · D-0399-2015Class IITerminatedMar 11, 2015Atracurium Besylate InjectionLack of Assurance of Sterility: Recall initiated due to FDA observations pertaining to aseptic and GMP practices at the manufacturers site potentially impacting product...Sagent Pharmaceuticals Inc · D-0398-2015Class IITerminatedMar 11, 2015AMLODIPINE BESYLATE TABLETS USPFailed tablet specifications: One lot was found to contain oversized tablets.Qualitest Pharmaceuticals · D-0397-2015Class IITerminatedMar 11, 2015Vancomycin Hydrochloride CapsulesSubpotent DrugActavis Inc · D-0396-2015Class IITerminatedMar 11, 2015Dextroamphetamine Sulfate Extended-Release CapsulesFailed Dissolution SpecificationsActavis Elizabeth LLC · D-0395-2015Class IITerminatedMar 4, 2015Ketorolac Tromethamine Ophthalmic SolutionPresence of Particulate Matter: lot is not meeting the specification limit for number of particles present in the solution.Sun Pharma Global Fze · D-0394-2015Class IITerminatedMar 4, 2015Mafenide AcetatePresence of Foreign Substance; oxidized steel, organic material and shredded polypropylenePar Pharmaceutical Inc. · D-0393-2015Class ITerminatedFeb 25, 2015LACTATED RINGER'S and 5% DEXTROSE Injection USPNon-Sterility: Confirmed customer complaint of particulate matter floating within the solution of the primary container, consistent with mold.Hospira Inc. · D-0392-2015Class ITerminatedFeb 25, 20151% LIDOCAINE HCl InjectionPresence of particulate matter: A returned customer sample was evaluated and found to have human hair attached to a pinched area of the stopper.Hospira Inc. · D-0391-2015Class IITerminatedFeb 25, 2015Vancomycin Hydrochloride for InjectionTemperature Abuse: Products experienced uncontrolled temperature excursions during transit.Hospira Inc. · D-0390-2015Class ITerminatedFeb 25, 2015Propofol Injectable EmulsionTemperature Abuse: Products experienced uncontrolled temperature excursions during transit.Hospira Inc. · D-0389-2015Class IITerminatedFeb 25, 2015Ketorolac Tromethamine InjTemperature Abuse: Products experienced uncontrolled temperature excursions during transit.Hospira Inc. · D-0388-2015Class IITerminatedFeb 25, 2015Vancomycin Hydrochloride for InjectionTemperature Abuse: Products experienced uncontrolled temperature excursions during transit.Hospira Inc. · D-0387-2015Class IITerminatedFeb 18, 2015Compounded PlaquexGood Manufacturing Practices Deviations: The product has an active pharmaceutical ingredient from an unapproved source.AnazaoHealth Corporation · D0384-2015Class IITerminatedFeb 18, 2015LevetiracetamFailed Dissolution Specifications: 6 month time point.Sun Pharma Global Fze · D-0386-2015Class IITerminatedFeb 18, 2015Erythromycin Pledgets USPMicrobial Contamination of Non-Sterile Products: Active Pharmaceutical Ingredient (API) failed USP microbial tests.Akorn, Inc. · D-0385-2015Class IITerminatedFeb 11, 2015Children's Loratadine SyrupPresence of Foreign Substance: Presence of blue plastic floating in loratadine syrup.Taro Pharmaceuticals U.S.A., Inc. · D-0383-2015

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.